HC Wainwright & Co. Reiterates Buy on Larimar Therapeutics, Maintains $15 Price Target

LARIMAR THERAPEUTICS INC -2.19%

LARIMAR THERAPEUTICS INC

LRMR

8.92

-2.19%

HC Wainwright & Co. analyst Edward White reiterates Larimar Therapeutics (NASDAQ: LRMR) with a Buy and maintains $15 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via